Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-18

FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for cilostazol submitted by Teva Pharmaceuticals USA, Inc., resulting in an approved modification to the product's l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)